In one paragraphArticle in Medicina (Kaunas, Lithuania), 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registryThe trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
3 · Its place in the literatureWho cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
4 · The recordCorrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what moneyAuthors and funding
9 authors.
Julia Węgrzynek-GallinaDepartment of Neurology, Faculty of Medical Sciences in Katowice, University Clinical Centre Prof K. Gibinski, Medical University of Silesia, 14 Medykow St. 40-752 Katowice, Poland.ORCID 0009-0004-7458-2856 Tomasz ChmielaDepartment of Neurology, Faculty of Medical Sciences in Katowice, University Clinical Centre Prof K. Gibinski, Medical University of Silesia, 14 Medykow St. 40-752 Katowice, Poland.ORCID 0000-0001-6022-7731 Michał BorończykDepartment of Neurology, School of Health Sciences, Medical University of Silesia in Katowice, 45/47 Ziolowa St., 40-635 Katowice, Poland.ORCID 0009-0007-8777-0997 Aleksandra BuczekStudents' Scientific Association, Department of Neurology, Faculty of Medical Sciences in Katowice, Medical University of Silesia, 14 Medykow St, 40-752 Katowice, Poland.
Patrycja HudzińskaStudents' Scientific Association, Department of Neurology, Faculty of Medical Sciences in Katowice, Medical University of Silesia, 14 Medykow St, 40-752 Katowice, Poland.
Hubert BigajskiStudents' Scientific Association, Department of Neurology, Faculty of Medical Sciences in Katowice, Medical University of Silesia, 14 Medykow St, 40-752 Katowice, Poland.
Damian WaksmundzkiStudents' Scientific Association, Department of Neurology, Faculty of Medical Sciences in Katowice, Medical University of Silesia, 14 Medykow St, 40-752 Katowice, Poland.
Justyna GawrylukDepartment of Neurology, Faculty of Medical Sciences in Katowice, University Clinical Centre Prof K. Gibinski, Medical University of Silesia, 14 Medykow St. 40-752 Katowice, Poland.
Joanna SiudaDepartment of Neurology, Faculty of Medical Sciences in Katowice, University Clinical Centre Prof K. Gibinski, Medical University of Silesia, 14 Medykow St. 40-752 Katowice, Poland.ORCID 0000-0002-0340-660X Funding
No grant is acknowledged in the PubMed record.
6 · The paper itselfAbstract
PubMed holds no abstract for this paper.
Indexed as
LevodopaParkinson DiseasePatient PreferencePatient SatisfactionAgedAged, 80 and overAntiparkinson AgentsApomorphineCarbidopaDrug CombinationsFemaleHumansInfusions, SubcutaneousMaleMiddle AgedSurveys and QuestionnairesAntiparkinson AgentsApomorphineCarbidopacarbidopa, levodopa drug combinationDrug CombinationsLevodopacontinuous subcutaneous apomorphine infusioninfusion therapieslevodopa–carbidopa intestinal gelParkinson’s diseasepatients’ preferences
Identifiers
PMID39859009
PMCPMC11766721
What OpenQuestion holds
Textmetadata
LicenceCC BY
Read underepoch 390